Though the Food and Drug Administration has released final guidelines for the regulation of mobile health applications, an internationally renowned expert in patient safety has called for the creation of mHealth app review and certification organizations to evaluate the vast majority of apps that remain unregulated.
In a viewpoint article published online today in the Journal of the American Medical Association, David Bates, M.D., senior vice president for quality and safety and chief quality officer for both Brigham and Womens Hospital and Brigham and Womens Physicians Organization, argues that the FDA has largely left the review and certification of apps to the marketplace.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access